You have 9 free searches left this month | for more free features.

City

Oxford (1)

Pittsburgh (1)

Condition

Uveal Melanoma (2)

Advanced Melanoma (1)

Melanoma (Skin) (1)

Melanoma, Uveal (1)

Overall Status

Not yet recruiting (2)

Available (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 2/phase 3 (1)

Sponsor

Immunocore Ltd (2)

Diwakar Davar (1)

University of Oxford (1)

Collaborator

Immunocore Ltd (2)

Clinigen, Inc. (1)

Natera, Inc. (1)

Intervention

tebentafusp (4)

investigators choice (1)

tebentafusp with pembrolizumab (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (3)

Expanded Access (1)

tebentafusp

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting

Uveal Melanoma

Tebentafusp

Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center

Oct 5, 2023

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting

Advanced Melanoma

Tebentafusp
+2 more

(no location specified)

Sep 19, 2022

Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)

Recruiting

Melanoma (Skin)
Melanoma, Uveal

Tebentafusp

Oxford, United Kingdom

Churchill Hospital, Oxford University Hospitals NHS Trust

Jul 28, 2022

Uveal Melanoma Trial (Tebentafusp)

Available

Uveal Melanoma

Tebentafusp

(no location specified)

Jan 5, 2022